Kloos R T
Division of Endocrinology and Metabolism, University of Michigan Medical Center, Ann Arbor 48109-0028, USA.
Medicine (Baltimore). 1995 Sep;74(5):268-80. doi: 10.1097/00005792-199509000-00004.
Spontaneous periodic hypothermia is a rare syndrome of recurrent, centrally mediated hypothermia without an identifiable systemic cause or brain lesion. Most patients defend a temporarily lowered temperature "set point" during episodes of hypothermia, despite manifesting many well-known systemic consequences of core temperature hypothermia. No case of death directly attributable to an episode of spontaneous periodic hypothermia has been reported, although many of the serious systemic effects of hypothermia have been documented in these cases, so it is not unlikely that death may occur. The syndrome's cause, and that of Shapiro syndrome, remains unknown. Pharmacologic trials to date have been only modestly successful. Anticonvulsant agents, clonidine, and cyproheptadine appear the most likely to succeed, with cyproheptadine being a reasonable first choice. Given that the term "spontaneous periodic hypothermia" describes a syndrome, and not a pathophysiologic mechanism, it is likely to encompass a common eventuality, arrived at via several different pathways. One can postulate mechanisms such as structural abnormalities, trauma, infection, irritation, and degeneration involving strategic locations which create a focus for epileptic or other periodic dysfunction whose scope involves the centers for thermoregulation. The existence of 2 distinct, oppositional thermoregulatory centers would allow for speculation of similar mechanisms accounting for cases of both periodic hypo- and hyperthermia (61). Postmortem data regarding the hypothalamic and surrounding areas from future cases of Shapiro syndrome and spontaneous periodic hypothermia would be of great interest. Further, more sensitive in vivo testing methods are clearly needed. The role of PET or single photon emission computed tomography (SPECT) with technetium 99m-labeled hexamethylpropylene amine oxime (Tc 99m HMPAO) performed acutely during an episode remains to be characterized (64, 103, 105). The term "diencephalic epilepsy" may in fact be accurate, given the periodic episodes of the case presented here and similar cases resulting from non-generalized seizure activity, with or without an underlying predisposing lesion. The label diencephalic epilepsy has been merely speculative so far, however, as definitive evidence of seizure activity has not been documented. Further, it is expected that the descriptive terms "spontaneous periodic hypothermia" and "episodic spontaneous hypothermia with hyperhidrosis" will outlive their usefulness as researchers gain greater understanding of this syndrome, and be replaced with a more pathophysiologically meaningful nomenclature.
自发性周期性体温过低是一种罕见的综合征,表现为反复出现的、由中枢介导的体温过低,且无明确的全身性病因或脑部病变。大多数患者在体温过低发作期间维持一个暂时降低的体温“设定点”,尽管会出现许多因核心体温过低而导致的众所周知的全身性后果。虽然在这些病例中已经记录了体温过低的许多严重全身性影响,但尚未有直接归因于自发性周期性体温过低发作的死亡病例报告,因此死亡仍有可能发生。该综合征以及夏皮罗综合征的病因仍然未知。迄今为止的药物试验仅取得了一定程度的成功。抗惊厥药、可乐定和赛庚啶似乎最有可能取得成功,赛庚啶是一个合理的首选药物。鉴于“自发性周期性体温过低”一词描述的是一种综合征,而非病理生理机制,它可能涵盖了通过几种不同途径导致的常见最终结果。人们可以推测其机制,如涉及关键部位的结构异常、创伤、感染、刺激和退化,这些会形成一个癫痫或其他周期性功能障碍的病灶,其范围涉及体温调节中枢。两个不同的、相互对立的体温调节中枢的存在,使得人们可以推测类似的机制可解释周期性体温过低和体温过高的病例(61)。来自未来夏皮罗综合征和自发性周期性体温过低病例的下丘脑及周围区域的尸检数据将非常有意义。此外,显然需要更敏感的体内检测方法。在发作期间急性进行的、使用锝99m标记的六甲基丙烯胺肟(Tc 99m HMPAO)的正电子发射断层扫描(PET)或单光子发射计算机断层扫描(SPECT)的作用仍有待确定(64, 103, 105)。鉴于此处所呈现病例的周期性发作以及由非全身性癫痫活动导致的类似病例(无论是否有潜在的易感病变),“间脑癫痫”这一术语实际上可能是准确的。然而,到目前为止,“间脑癫痫”这一标签仅仅是推测性的,因为尚未记录到癫痫活动的确切证据。此外,随着研究人员对该综合征有更深入的了解,预计“自发性周期性体温过低”和“伴有多汗的发作性自发性体温过低”这些描述性术语将不再适用,并被更具病理生理学意义的命名所取代。